futurefuel10q.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark
One)
√
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For
the quarterly period ended September 30, 2008
OR
|
|
|
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For
the transition period from
_____________
|
Commission
file number: 0-52577
FUTUREFUEL
CORP.
(Exact
Name of Registrant as Specified in Its Charter)
Delaware
|
|
20-3340900
|
(State
or Other Jurisdiction of Incorporation or Organization)
|
|
(IRS
Employer Identification No.)
|
8235
Forsyth Blvd., Suite 400
St.
Louis, Missouri 63105
(Address
of Principal Executive Offices)
(314)
854-8520
(Registrant’s
Telephone Number)
Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.
Yes No √
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes No √
Indicate
the number of shares outstanding of each of the issuer’s classes of common
stock, as of November 13, 2008: 28,150,500
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of “large accelerated filer,”
“accelerated filer” and “smaller reporting company” in Rule 12b-2 of the
Exchange Act. (Check one):
Large
accelerated filer
|
Accelerated
filer
|
Non-accelerated
filer √
|
Smaller
reporting company
|
PART
I
FINANCIAL
INFORMATION
Item
1. Financial Statements.
The
following sets forth our unaudited consolidated balance sheet as at
September 30, 2008 and our audited consolidated balance sheet as at
December 31, 2007, the unaudited consolidated statements of operations and
comprehensive income for the three- and nine-month periods ended
September 30, 2008 and September 30, 2007, and the unaudited
consolidated statements of cash flow for the nine-month periods ended
September 30, 2008 and September 30, 2007.
FutureFuel
Corp.
Consolidated
Balance Sheets
As
at September 30, 2008 and December 31, 2007
(Dollars
in thousands)
|
|
(Unaudited)
September 30, 2008
|
|
|
December 31,
2007
|
|
Assets
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$ |
27,427 |
|
|
$ |
54,655 |
|
Accounts
receivable, net of allowances for doubtful accounts of
$0 at September 30, 2008 and $42 at December 31,
2007
|
|
|
20,379 |
|
|
|
17,514 |
|
Inventory
|
|
|
25,242 |
|
|
|
24,192 |
|
Income taxes
receivable
|
|
|
1,126 |
|
|
|
- |
|
Prepaid expenses
|
|
|
335 |
|
|
|
1,200 |
|
Marketable debt and auction rate
securities
|
|
|
57,519 |
|
|
|
15,086 |
|
Other current
assets
|
|
|
1,212 |
|
|
|
541 |
|
Total current
assets
|
|
|
133,240 |
|
|
|
113,188 |
|
Property, plant and equipment,
net
|
|
|
104,756 |
|
|
|
95,036 |
|
Restricted cash and cash
equivalents
|
|
|
- |
|
|
|
3,263 |
|
Intangible assets
|
|
|
349 |
|
|
|
435 |
|
Other assets
|
|
|
3,148 |
|
|
|
4,191 |
|
Total noncurrent
assets
|
|
|
108,253 |
|
|
|
102,925 |
|
Total
Assets
|
|
$ |
241,493 |
|
|
$ |
216,113 |
|
Liabilities
and Stockholders’ Equity
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$ |
14,209 |
|
|
$ |
12,622 |
|
Accounts payable – related
parties
|
|
|
471 |
|
|
|
121 |
|
Income taxes
payable
|
|
|
- |
|
|
|
1,231 |
|
Current deferred income tax
liability
|
|
|
4,105 |
|
|
|
4,597 |
|
Short term contingent
consideration
|
|
|
400 |
|
|
|
197 |
|
Line of credit
|
|
|
343 |
|
|
|
- |
|
Accrued expense and other current
liabilities
|
|
|
4,139 |
|
|
|
3,370 |
|
Total current
liabilities
|
|
|
23,667 |
|
|
|
22,138 |
|
Long term contingent
consideration
|
|
|
1,569 |
|
|
|
1,989 |
|
Deferred revenue
|
|
|
9,032 |
|
|
|
1,571 |
|
Other noncurrent
liabilities
|
|
|
1,221 |
|
|
|
1,126 |
|
Noncurrent deferred income tax
liability
|
|
|
20,953 |
|
|
|
19,667 |
|
Total noncurrent
liabilities
|
|
|
32,775 |
|
|
|
24,353 |
|
Total
Liabilities
|
|
|
56,442 |
|
|
|
46,491 |
|
Commitments
and contingencies
|
|
|
|
|
|
|
|
|
Preferred
stock, $0.0001 par value, 5,000,000 shares authorized, none issued and
outstanding
|
|
|
- |
|
|
|
- |
|
Common
stock, $0.0001 par value, 75,000,000 shares authorized,
26,835,000 issued and outstanding at September 30, 2008
and 26,700,000 issued and outstanding at December 31,
2007
|
|
|
3 |
|
|
|
3 |
|
Accumulated other comprehensive
income
|
|
|
- |
|
|
|
58 |
|
Additional paid in
capital
|
|
|
159,461 |
|
|
|
158,436 |
|
Retained earnings
|
|
|
25,587 |
|
|
|
11,125 |
|
Total stockholders’
equity
|
|
|
185,051 |
|
|
|
169,622 |
|
Total
Liabilities and Stockholders’ Equity
|
|
$ |
241,493 |
|
|
$ |
216,113 |
|
The
accompanying notes are an integral part of these financial
statements.
FutureFuel
Corp.
Consolidated
Statements of Operations and Comprehensive Income
For
the Three Months Ended September 30, 2008 and 2007
(Dollars
in thousands, except per share amounts)
(Unaudited)
|
Three
Months Ended
September 30,
|
Revenues
|
|
$ |
57,183 |
|
|
$ |
46,558 |
|
Revenues
– related parties
|
|
|
3,402 |
|
|
|
- |
|
Cost
of goods sold
|
|
|
44,611 |
|
|
|
38,787 |
|
Cost
of goods sold – related parties
|
|
|
3,950 |
|
|
|
451 |
|
Distribution
|
|
|
1,144 |
|
|
|
435 |
|
Gross
profit
|
|
|
10,880 |
|
|
|
6,885 |
|
Selling,
general and administrative expenses
|
|
|
|
|
|
|
|
|
Compensation
expense
|
|
|
652 |
|
|
|
926 |
|
Formation expense
|
|
|
- |
|
|
|
43 |
|
Other expense
|
|
|
385 |
|
|
|
321 |
|
Related party
expense
|
|
|
38 |
|
|
|
11 |
|
Research
and development expenses
|
|
|
1,079 |
|
|
|
946 |
|
|
|
|
2,154 |
|
|
|
2,247 |
|
Income
from operations
|
|
|
8,726 |
|
|
|
4,638 |
|
Interest
income
|
|
|
671 |
|
|
|
877 |
|
Interest
expense
|
|
|
(6 |
) |
|
|
(5 |
) |
Gain
(loss) on foreign currency
|
|
|
(89 |
) |
|
|
2 |
|
Loss
on sale of marketable debt securities
|
|
|
(460 |
) |
|
|
- |
|
|
|
|
116 |
|
|
|
874 |
|
Income
before income taxes
|
|
|
8,842 |
|
|
|
5,512 |
|
Provision
for income taxes
|
|
|
3,453 |
|
|
|
2,169 |
|
Net
income
|
|
$ |
5,389 |
|
|
$ |
3,343 |
|
|
|
|
|
|
|
|
|
|
Earnings
per common share
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
0.20 |
|
|
$ |
0.13 |
|
Diluted
|
|
$ |
0.19 |
|
|
$ |
0.10 |
|
Weighted
average shares outstanding
|
|
|
|
|
|
|
|
|
Basic
|
|
|
26,787,609 |
|
|
|
26,700,000 |
|
Diluted
|
|
|
28,821,986 |
|
|
|
32,286,294 |
|
|
|
|
|
|
|
|
|
|
Comprehensive
Income
|
|
|
|
|
|
|
|
|
Net
income
|
|
$ |
5,389 |
|
|
$ |
3,343 |
|
Other
comprehensive income (loss), net of tax of $(52) in 2008 and
$11
in 2007
|
|
|
(87 |
) |
|
|
17 |
|
Comprehensive
income
|
|
$ |
5,302 |
|
|
$ |
3,360 |
|
The
accompanying notes are an integral part of these financial
statements.
FutureFuel
Corp.
Consolidated
Statements of Operations and Comprehensive Income
For
the Nine Months Ended September 30, 2008 and 2007
(Dollars
in thousands, except per share amounts)
(Unaudited)
|
|
Nine
Months Ended
September 30,
|
|
|
2008
|
|
|
2007
|
|
Revenues
|
|
$ |
150,299 |
|
|
$ |
125,645 |
|
Revenues
– related parties
|
|
|
3,402 |
|
|
|
40 |
|
Cost
of goods sold
|
|
|
119,544 |
|
|
|
113,407 |
|
Cost
of goods sold – related parties
|
|
|
5,532 |
|
|
|
1,064 |
|
Distribution
|
|
|
2,713 |
|
|
|
1,195 |
|
Gross
profit
|
|
|
25,912 |
|
|
|
10,019 |
|
Selling,
general and administrative expenses
|
|
|
|
|
|
|
|
|
Compensation
expense
|
|
|
1,980 |
|
|
|
1,687 |
|
Formation expense
|
|
|
- |
|
|
|
117 |
|
Other expense
|
|
|
938 |
|
|
|
1,025 |
|
Related party
expense
|
|
|
142 |
|
|
|
94 |
|
Research
and development expenses
|
|
|
3,042 |
|
|
|
2,616 |
|
|
|
|
6,102 |
|
|
|
5,539 |
|
Income
from operations
|
|
|
19,810 |
|
|
|
4,480 |
|
Interest
income
|
|
|
2,286 |
|
|
|
2,695 |
|
Interest
expense
|
|
|
(17 |
) |
|
|
(18 |
) |
Gain
on foreign currency
|
|
|
293 |
|
|
|
7 |
|
Loss
on sale of marketable debt securities
|
|
|
(377 |
) |
|
|
- |
|
Other
income (expense)
|
|
|
6 |
|
|
|
(68 |
) |
|
|
|
2,191 |
|
|
|
2,616 |
|
Income
before income taxes
|
|
|
22,001 |
|
|
|
7,096 |
|
Provision
for income taxes
|
|
|
7,539 |
|
|
|
2,886 |
|
Net
income
|
|
$ |
14,462 |
|
|
$ |
4,210 |
|
|
|
|
|
|
|
|
|
|
Earnings
per common share
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
0.54 |
|
|
$ |
0.16 |
|
Diluted
|
|
$ |
0.53 |
|
|
$ |
0.13 |
|
Weighted
average shares outstanding
|
|
|
|
|
|
|
|
|
Basic
|
|
|
26,729,416 |
|
|
|
26,700,000 |
|
Diluted
|
|
|
27,419,338 |
|
|
|
32,274,327 |
|
|
|
|
|
|
|
|
|
|
Comprehensive
Income
|
|
|
|
|
|
|
|
|
Net
income
|
|
$ |
14,462 |
|
|
$ |
4,210 |
|
Other
comprehensive income (loss), net of tax of $(35) in 2008 and
$11
in 2007
|
|
|
(58 |
) |
|
|
17 |
|
Comprehensive
income
|
|
$ |
14,404 |
|
|
$ |
4,227 |
|
The
accompanying notes are an integral part of these financial
statements.
FutureFuel
Corp.
Consolidated
Statements of Cash Flows
For
the Nine Months Ended September 30, 2008 and 2007
(Dollars
in thousands)
(Unaudited)
|
|
Nine
Months Ended September 30,
|
|
|
2008
|
|
|
2007
|
Cash
flows provide by operating activities
|
|
|
|
Net income
|
|
$ |
14,462 |
|
|
$ |
4,210 |
|
Adjustments
to reconcile net income to net cash provided by
operating
activities:
|
|
|
|
|
|
|
|
|
Depreciation
|
|
|
4,180 |
|
|
|
3,388 |
|
Provision
for deferred income taxes
|
|
|
829 |
|
|
|
1,249 |
|
Change
in fair value of derivative instruments
|
|
|
1,669 |
|
|
|
1,095 |
|
Loss
on the sale of investments
|
|
|
377 |
|
|
|
- |
|
Accretion
of the discount of marketable debt securities
|
|
|
(103 |
) |
|
|
- |
|
Losses
on disposals of fixed assets
|
|
|
10 |
|
|
|
112 |
|
Stock
based compensation
|
|
|
411 |
|
|
|
- |
|
Noncash
interest expense
|
|
|
16 |
|
|
|
16 |
|
Changes
in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
(2,865 |
) |
|
|
6,554 |
|
Inventory
|
|
|
(1,806 |
) |
|
|
(2,351 |
) |
Income
taxes receivable
|
|
|
(1,126 |
) |
|
|
- |
|
Prepaid expenses
|
|
|
866 |
|
|
|
984 |
|
Accrued interest on marketable
debt securities
|
|
|
50 |
|
|
|
- |
|
Other assets
|
|
|
1,043 |
|
|
|
(1,017 |
) |
Accounts payable
|
|
|
1,587 |
|
|
|
5,909 |
|
Accounts
payable – related parties
|
|
|
350 |
|
|
|
166 |
|
Income taxes
payable
|
|
|
(1,231 |
) |
|
|
(1,490 |
) |
Accrued expense and other current
liabilities
|
|
|
769 |
|
|
|
128 |
|
Accrued
expense and other current liabilities – related parties
|
|
|
- |
|
|
|
(40 |
) |
Deferred
revenue
|
|
|
7,461 |
|
|
|
- |
|
Other
noncurrent liabilities
|
|
|
80 |
|
|
|
190 |
|
Net
cash provided by operating activities
|
|
|
27,029 |
|
|
|
19,103 |
|
Cash
flows used in investing activities
|
|
|
|
|
|
|
|
|
Restricted cash
|
|
|
3,263 |
|
|
|
(109 |
) |
Collateralization of derivative
instruments
|
|
|
(2,240 |
) |
|
|
1,352 |
|
Purchase of marketable
securities
|
|
|
(56,807 |
) |
|
|
(14,803 |
) |
Proceeds from the sale of
marketable securities
|
|
|
39,557 |
|
|
|
- |
|
Net purchases of auction rate
securities
|
|
|
(25,600 |
) |
|
|
- |
|
Proceeds from the sale of fixed
assets
|
|
|
8 |
|
|
|
- |
|
Contingent purchase price
payment
|
|
|
(218 |
) |
|
|
(140 |
) |
Capital
expenditures
|
|
|
(13,177 |
) |
|
|
(14,419 |
) |
Net
cash used in investing activities
|
|
|
(55,214 |
) |
|
|
(28,119 |
) |
Cash
flows provided by (used in) financing activities
|
|
|
|
|
|
|
|
|
Proceeds from line of
credit
|
|
|
343 |
|
|
|
- |
|
Proceeds from the issuance of
stock
|
|
|
592 |
|
|
|
- |
|
Excess tax benefit associated
with stock options
|
|
|
22 |
|
|
|
- |
|
Financing fee
|
|
|
- |
|
|
|
(50 |
) |
Net cash provided by (used in)
financing activities
|
|
|
957 |
|
|
|
(50 |
) |
Net
change in cash and cash equivalents
|
|
|
(27,228 |
) |
|
|
(9,066 |
) |
Cash
and cash equivalents at beginning of period
|
|
|
54,655 |
|
|
|
63,129 |
|
Cash
and cash equivalents at end of period
|
|
$ |
27,427 |
|
|
$ |
54,063 |
|
Cash
paid for interest
|
|
$ |
1 |
|
|
$ |
3 |
|
Cash
paid for taxes
|
|
$ |
8,967 |
|
|
$ |
2,992 |
|
The
accompanying notes are an integral part of these financial
statements.
Notes
to Consolidated Financial Statements of FutureFuel Corp.
(Dollars
in thousands, except per share amounts)
(Unaudited)
1) Nature
of operations and basis of presentation
FutureFuel
Corp.
Viceroy
Acquisition Corporation (“Viceroy”) was incorporated under the laws of the state
of Delaware on August 12, 2005 to serve as a vehicle for the acquisition by
way of asset acquisition, merger, capital stock exchange, share purchase or
similar transaction of one or more operating businesses in the oil and gas
industry. On July 12, 2006 Viceroy completed an equity
offering.
On
July 21, 2006, Viceroy entered into an acquisition agreement with Eastman
Chemical Company (“Eastman Chemical”) to purchase all of the issued and
outstanding stock of Eastman SE, Inc. (“Eastman SE”). On
October 27, 2006, a special meeting of the shareholders of Viceroy was held
and the acquisition of Eastman SE was approved by the
shareholders. On October 31, 2006, Viceroy acquired all of the
issued and outstanding shares of Eastman SE from Eastman
Chemical. Immediately subsequent to the acquisition, Viceroy changed
its name to FutureFuel Corp. (“FutureFuel”) and Eastman SE changed its name to
FutureFuel Chemical Company (“FutureFuel Chemical”).
Eastman
SE, Inc.
Eastman
SE was incorporated under the laws of the state of Delaware on September 1,
2005 and subsequent thereto operated as a wholly-owned subsidiary of Eastman
Chemical through October 31, 2006. Eastman SE was incorporated
for purposes of effecting a sale of Eastman Chemical’s manufacturing facility in
Batesville, Arkansas (the “Batesville Plant”). Commencing
January 1, 2006, Eastman Chemical began transferring the assets associated
with the business of the Batesville Plant to Eastman SE.
The
Batesville Plant was constructed to produce proprietary photographic chemicals
for Eastman Kodak Company (“Eastman Kodak”). Over the years, Eastman
Kodak shifted the plant’s focus away from the photographic imaging business to
the custom synthesis of fine chemicals and organic chemical intermediates used
in a variety of end markets, including paints and coatings, plastics and
polymers, pharmaceuticals, food supplements, household detergents and
agricultural products.
In 2005,
the Batesville Plant began the implementation of a biobased products
platform. This includes the production of biofuels (biodiesel,
bioethanol and lignin/biomass solid fuels) and biobased specialty chemical
products (biobased solvents, chemicals and intermediates). In
addition to biobased products, the Batesville Plant continues to manufacture
fine chemicals and other organic chemicals.
The
accompanying consolidated financial statements have been prepared by FutureFuel
in accordance and consistent with the accounting policies stated in FutureFuel’s
2007 audited consolidated financial statements and should be read in conjunction
with the 2007 audited consolidated financial statements of
FutureFuel. Certain prior year balances have been reclassified to
conform with the current year presentation.
In the
opinion of FutureFuel, all normal recurring adjustments necessary for a fair
presentation have been included in the unaudited consolidated financial
statements. The unaudited consolidated financial statements are
presented in conformity with generally accepted accounting principles in the
United States and, of necessity, include some amounts that are based upon
management estimates and judgments. Future actual results could
differ from such current estimates. The unaudited consolidated
financial statements include assets, liabilities, revenues and expenses of
FutureFuel and its wholly owned subsidiary, FutureFuel
Chemical. Intercompany transactions and balances have been eliminated
in consolidation.
Notes
to Consolidated Financial Statements of FutureFuel Corp.
(Dollars
in thousands, except per share amounts)
(Unaudited)
2) Inventories
The
carrying values of inventory were as follows as of:
|
|
September 30,
2008
|
|
|
December 31,
2007
|
|
At
first-in, first-out or average cost (approximates current
cost)
|
|
|
|
|
|
|
Finished goods
|
|
$ |
11,857 |
|
|
$ |
8,993 |
|
Work in process
|
|
|
1,718 |
|
|
|
1,091 |
|
Raw materials and
supplies
|
|
|
17,476 |
|
|
|
15,670 |
|
|
|
|
31,051 |
|
|
|
25,754 |
|
LIFO reserve
|
|
|
(5,809 |
) |
|
|
(1,562 |
) |
Total inventories
|
|
$ |
25,242 |
|
|
$ |
24,192 |
|
3) Derivative
instruments
The
volumes and carrying values of FutureFuel’s derivative instruments were as
follows at:
|
|
Asset/(Liability)
|
|
|
|
September 30,
2008
|
|
|
December 31,
2007
|
|
|
|
Quantity
(Contracts) Long/
(Short)
|
|
|
Fair
Market
Value
|
|
|
Quantity
(Contracts) Long/
(Short)
|
|
|
Fair
Market
Value
|
|
Regulated
fixed price future
commitments, included in prepaid
expenses and other current assets
|
|
|
50 |
|
|
$ |
(386 |
) |
|
|
- |
|
|
$ |
- |
|
Regulated
options, included in prepaid
expenses and other current assets
|
|
|
(200 |
) |
|
$ |
(1,530 |
) |
|
|
(100 |
) |
|
$ |
(247 |
) |
The
margin account maintained with a broker to collateralize these derivative
instruments carried an account balance of $3,028 and $788 at September 30,
2008 and December 31, 2007, respectively, and is classified as other
current assets in the consolidated balance sheet. The carrying values
of the margin account and of the derivative instruments are included, net, in
other current assets.
4) Marketable
debt securities
At
September 30, 2008, FutureFuel had investments in certain U.S. treasury
bills and notes. These investments had maturity dates ranging from
November 2008 to March 2009 and have been classified as current assets in the
accompanying consolidated balance sheet. FutureFuel has designated
these securities as being available-for-sale; accordingly, they are recorded at
fair value, with the unrealized gains and losses, net of taxes, reported as a
component of stockholders’ equity. The fair market value of these
investments, including accrued interest, totaled $31,900 at September 30,
2008. The fair market value of similar investments, including accrued
interest, totaled $15,086 at December 31, 2007.
Additionally,
as of September 30, 2008, FutureFuel had made investments in certain
auction rate securities. As of September 30, 2008, these
securities had maturities ranging from June 2028 to July
2042. FutureFuel has classified these instruments as current assets
in the accompanying consolidated balance sheet as the issuers have either
exercised their right to repurchase or a liquid market still exists for these
securities, which allows FutureFuel to exit its positions within a short period
of time. FutureFuel anticipates these securities either being sold or
repurchased within the next year. Therefore, regardless of their
maturity dates, FutureFuel has classified these investments as
current. FutureFuel has designated these securities as being
available-for-sale. Accordingly, these securities are carried at fair
value, with unrealized gains and losses, net of taxes, reported as a component
of stockholders’ equity. No realized gains or losses have been
incurred related to these securities through September 30,
2008.
Notes
to Consolidated Financial Statements of FutureFuel Corp.
(Dollars
in thousands, except per share amounts)
(Unaudited)
The fair
market value of auction rate securities approximated their par value and,
including accrued interest, totaled $25,619 at September 30,
2008. No auction rate securities were held by FutureFuel at
December 31, 2007.
5) Accrued
expense and other current liabilities
Accrued
expense and other current liabilities, including those associated with related
parties, consisted of the following at:
|
|
September 30,
2008
|
|
|
December 31,
2007
|
|
Accrued
employee liabilities
|
|
$ |
2,412 |
|
|
$ |
1,722 |
|
Accrued
property, use and franchise taxes
|
|
|
1,680 |
|
|
|
1,110 |
|
Accrued
professional fees
|
|
|
- |
|
|
|
30 |
|
Other
|
|
|
47 |
|
|
|
508 |
|
Total
|
|
$ |
4,139 |
|
|
$ |
3,370 |
|
6) Borrowings
In March
2007 FutureFuel Chemical entered into a $50 million credit agreement with a
commercial bank. The loan is a revolving facility the proceeds of
which may be used for working capital, capital expenditures and the general
corporate purposes of FutureFuel Chemical. The facility terminates in
March 2010. Advances are made pursuant to a borrowing base comprised
of 85% of eligible accounts plus 60% of eligible direct inventory plus 50% of
eligible indirect inventory. Advances are secured by a perfected
first priority security interest in accounts receivable and
inventory. The interest rate floats at certain margins over the
London Interbank Offered Rate (“LIBOR”) or base rate based upon the leverage
ratio from time to time as set forth in the following table.
Leverage
Ratio
|
|
Base
Rate
Margin
|
|
LIBOR
Margin
|
>
3
|
|
-0.55%
|
|
1.70%
|
≥ 2 <
3
|
|
-0.70%
|
|
1.55%
|
≥
1 < 2
|
|
-0.85%
|
|
1.40%
|
<
1
|
|
-1.00%
|
|
1.25%
|
There is
an unused commitment fee of 0.25% per annum. Beginning
December 31, 2007, and on the last day of each fiscal quarter thereafter,
the ratio of EBITDA to fixed charges may not be less than
1.5:1. Beginning June 30, 2007, the ratio of total funded debt
to EBITDA may not exceed 3.50:1, reduced to 3.25:1 at March 31, 2008,
June 30, 2008 and September 30, 2008, and then 3:1
thereafter. FutureFuel has guaranteed FutureFuel Chemical’s
obligations under this credit agreement.
At
September 30, 2008, borrowings of $343 were outstanding under this credit
facility.
7) Stock
based compensation
The board
of directors of FutureFuel adopted an omnibus incentive plan which was approved
by the shareholders of FutureFuel at its 2007 annual shareholder meeting on
June 26, 2007. The purpose of the plan is to:
|
·
|
Encourage
ownership in FutureFuel by key personnel whose long-term employment with
or engagement by FutureFuel or its subsidiaries is considered essential to
its continued progress and, thereby, encourage recipients to act in
FutureFuel’s shareholders’ interests and share in its
success;
|
|
·
|
Encourage
such persons to remain in FutureFuel’s employ or in the employ of its
subsidiaries; and
|
Notes
to Consolidated Financial Statements of FutureFuel Corp.
(Dollars
in thousands, except per share amounts)
(Unaudited)
|
·
|
Provide
incentives to persons who are not FutureFuel employees to promote
FutureFuel’s success.
|
The plan
authorizes FutureFuel to issue stock options (including incentive stock options
and nonqualified stock options), stock awards and stock appreciation
rights. Eligible participants in the plan include: (i) members
of FutureFuel’s board of directors and its executive officers;
(ii) regular, active employees of FutureFuel and any of its subsidiaries;
and (iii) persons engaged by FutureFuel or any of its subsidiaries to
render services to FutureFuel or its subsidiaries as an advisor or
consultant.
Awards
under the plan are limited to shares of FutureFuel’s common stock, which may be
shares acquired by FutureFuel, including shares purchased in the open market, or
authorized but un-issued shares. Awards are limited to 10% of the
issued and outstanding shares of FutureFuel’s common stock in the
aggregate.
The plan
became effective upon its approval by FutureFuel’s shareholders on June 26,
2007 and continues in effect for a term of ten years thereafter unless amended
and extended by FutureFuel or unless otherwise terminated.
FutureFuel
has adopted Statement of Financial Accounting Standards No. 123 (Revised 2004),
Share-Based Payment
(“SFAS No. 123(R)”) and related interpretations and began recognizing
compensation expense in its financial statements for stock based options based
upon the grant-date fair value over the requisite service period.
In April
2008, FutureFuel granted a total of 250,000 stock options to members of its
board of directors (“Director Options”). Additionally, it granted a
total of 55,000 stock options to selected members of its management (“Management
Options”). An additional 5,000 Management Options were issued in
September 2008. The options awarded in April 2008 have an exercise
price equal to the average of the bid and ask price of FutureFuel’s common stock
on the date of grant as established in private sales, which the board of
directors determined to be the fair market value of such stock on that
date. The Management Options awarded in September 2008 have an
exercise price equal to the closing price of FutureFuel’s common stock on the
date of grant as quoted on the Over-the-Counter Bulletin Board. The
Director Options vested immediately upon grant. Originally, one-third
of the Management Options granted in April 2008 vested on each of the annual
anniversary dates of the grant. Those Management Options were amended
in September 2008 to provide for immediate vesting. The Management
Options issued in September 2008 vested immediately upon grant. Both
the Director Options and the Management Options awarded in April 2008 expire on
April 7, 2013. The Management Options awarded in September 2008
expire on September 30, 2013. FutureFuel has utilized the Black
Scholes Merton option pricing model, which relies on certain assumptions, to
estimate the fair value of the options it granted.
The
assumptions used in the determination of the fair value of the options granted
are provided in the following table:
Assumptions
|
|
Director
Options
|
|
April
2008
Management
Options
|
|
September
2008
Management
Options
|
Expected
volatility rate
|
|
46.78%
|
|
48.74%
|
|
50.63%
|
Expected
dividend yield
|
|
0.00%
|
|
0.00%
|
|
0.00%
|
Risk-free
interest rate
|
|
2.03%
|
|
2.26%
|
|
2.22%
|
Expected
forfeiture rate
|
|
0.00%
|
|
0.00%
|
|
0.00%
|
Expected
term in years
|
|
2.50
|
|
3.50
|
|
2.50
|
The
volatility rate for the options granted is derived from the historical stock
price volatility of a peer group of companies over the same time period as the
expected term of each stock option award. The volatility rate is
derived by a mathematical formula utilizing the daily closing stock price data
over the expected term. It is FutureFuel’s expectation that
volatility rates for future stock option grants will be based on FutureFuel’s
historical stock price volatility as FutureFuel develops a lengthier stock
trading history.
Notes
to Consolidated Financial Statements of FutureFuel Corp.
(Dollars
in thousands, except per share amounts)
(Unaudited)
The
expected dividend yield is calculated using FutureFuel’s expected dividend
amount at the date of the option grant over the expected term divided by the
fair market value of FutureFuel’s common stock.
The
risk-free interest rate is derived from the United States Federal Reserve’s
published interest rates of daily yields for the same time period as the
expected term.
SFAS No.
123(R) specifies that only share-based awards expected to vest are to be
included in share-based compensation expense. The estimated
forfeiture rates are based upon FutureFuel’s expected rate of forfeiture and are
excluded from the quantity of awards included in share-based compensation
expense.
FutureFuel
has not historically granted stock options and therefore does not have a
historical record of share-based award transactions on which to base an estimate
of expected term. FutureFuel has therefore elected to utilize the
“simplified” method of estimating expected term as discussed in Staff Accounting
Bulletins No. 107 and No. 110.
For the
three- and nine-month periods ended September 30, 2008, total share-based
compensation expense (before tax) totaled $84 and $411,
respectively. In the three-month period ended September 30,
2008, $58, $13 and $13 of this balance was recorded as an element of selling,
general and administrative expense, cost of goods sold and research and
development expense, respectively. In the nine-month period ended
September 30, 2008, $382, $15 and $14 of this balance was recorded as an
element of selling, general and administrative expense, cost of goods sold and
research and development expense, respectively.
A summary
of the activity of FutureFuel’s stock option awards for the period beginning
January 1, 2008 and ending September 30, 2008 is presented
below:
|
|
Options
|
|
|
Weighted-Average
Exercise Price
|
|
Outstanding
at January 1, 2008
|
|
|
- |
|
|
|
- |
|
Granted
|
|
|
310,000 |
|
|
$ |
4.04 |
|
Exercised
|
|
|
110,000 |
|
|
$ |
4.00 |
|
Cancelled,
forfeited or expired
|
|
|
- |
|
|
|
- |
|
Outstanding
at September 30, 2008
|
|
|
200,000 |
|
|
$ |
4.06 |
|
|
|
|
|
|
|
|
|
|
Weighted
average remaining contractual life
|
|
4.53
years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options
exercisable at September 30, 2008
|
|
|
200,000 |
|
|
$ |
4.06 |
|
|
|
|
|
|
|
|
|
|
Weighted
average fair value of the options granted
|
|
|
n/a |
|
|
$ |
1.33 |
|
|
|
|
|
|
|
|
|
|
Available
for grant at September 30, 2008
|
|
|
2,360,000 |
|
|
|
n/a |
|
The
following table provides the remaining contractual term and weighted average
exercise prices of stock options outstanding and exercisable at
September 30, 2008:
|
|
Options
Outstanding
|
|
Options
Exercisable
|
Exercise
Price
|
|
Number
Outstanding
at
September 30,
2008
|
|
Weighted-
Average
Remaining
Contractual
Life
|
|
Weighted-
Average
Exercise
Price
|
|
Number
Exercisable
at September 30,
2008
|
|
Weighted-
Average
Exercise
Price
|
$ 4.00
|
|
195,000
|
|
4.52
years
|
|
$ 4.00
|
|
195,000
|
|
$ 4.00
|
$ 6.48
|
|
5,000
|
|
5.00
years
|
|
$ 6.48
|
|
5,000
|
|
$ 6.48
|
The
weighted average remaining contractual life of all exercisable options is 4.53
years.
Notes
to Consolidated Financial Statements of FutureFuel Corp.
(Dollars
in thousands, except per share amounts)
(Unaudited)
The
aggregate intrinsic values of total options outstanding and total options
exercisable at September 30, 2008 are $488 and $488,
respectively. Intrinsic value is the amount by which the last trade
price of the common stock closest to September 30, 2008 exceeded the
exercise price of the options granted.
The
amendment of the Management Options in September 2008 referred to above resulted
in the immediate recognition into expense of the estimated fair value of those
options not previously recognized, which totaled $74.
8) Provision
for income taxes
|
|
For
the three months ended September 30,
|
|
|
For
the nine months ended September 30,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
Provision
for income taxes
|
|
$ |
3,453 |
|
|
$ |
2,169 |
|
|
$ |
7,539 |
|
|
$ |
2,886 |
|
Effective
tax rate
|
|
|
39.1 |
% |
|
|
39.4 |
% |
|
|
34.3 |
% |
|
|
40.7 |
% |
The
effective tax rates for the three and nine months ended September 30, 2008
and 2007 reflect FutureFuel’s expected tax rate on reported operating earnings
before income tax.
FutureFuel’s
unrecognized tax benefits, recorded as an element of other noncurrent
liabilities, totaled $559 at September 30, 2008 and December 31, 2007,
the total amount of which, if recognized, would reduce FutureFuel’s effective
tax rate.
FutureFuel
does not expect its unrecognized tax benefits to change significantly over the
next 12 months.
FutureFuel
records interest and penalties net as a component of income tax
expense. FutureFuel had accrued a balance of $80 and $0 at
September 30, 2008 and December 31, 2007, respectively, for interest
or tax penalties.
FutureFuel
and its subsidiary, FutureFuel Chemical, file tax returns in the U.S. federal
jurisdiction and with various state jurisdictions. FutureFuel was
incorporated in 2005 and is subject to U.S., state and local examinations by tax
authorities from 2005 forward. FutureFuel Chemical is subject to the
effects of tax examinations that may impact the carry-over basis of its assets
and liabilities.
9) Earnings
per share
The
computation of basic and diluted earnings per common share was as
follows:
|
For
the three months ended September 30,
|
|
|
For
the nine months ended September 30,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
Net
income available to common stockholders
|
|
$ |
5,389 |
|
|
$ |
3,343 |
|
|
$ |
14,462 |
|
|
$ |
4,210 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average number of common shares outstanding
|
|
|
26,787,609 |
|
|
|
26,700,000 |
|
|
|
26,729,416 |
|
|
|
26,700,000 |
|
Effect
of warrants
|
|
|
1,948,721 |
|
|
|
5,586,294 |
|
|
|
649,574 |
|
|
|
5,574,327 |
|
Effect
of stock options
|
|
|
85,656 |
|
|
|
- |
|
|
|
40,348 |
|
|
|
- |
|
Weighted
average diluted number of common shares outstanding
|
|
|
28,821,986 |
|
|
|
32,286,294 |
|
|
|
27,419,338 |
|
|
|
32,274,327 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
earnings per share
|
|
$ |
0.20 |
|
|
$ |
0.13 |
|
|
$ |
0.54 |
|
|
$ |
0.16 |
|
Diluted
earnings per share
|
|
$ |
0.19 |
|
|
$ |
0.10 |
|
|
$ |
0.53 |
|
|
$ |
0.13 |
|
Certain
warrants to purchase shares of FutureFuel’s common stock were not included in
the computation of diluted earnings per share for the nine-month period ended
September 30, 2008 as they were anti-dilutive in the period. The
weighted average number of warrants excluded on this basis was 15,000,000 for
the nine months ended September 30, 2008.
Notes
to Consolidated Financial Statements of FutureFuel Corp.
(Dollars
in thousands, except per share amounts)
(Unaudited)
10) Segment
information
FutureFuel
has determined that is has two reportable segments organized along product lines
– chemicals and biofuels.
Chemicals
FutureFuel’s
chemicals segment manufactures diversified chemical products that are sold
externally to third party customers. This segment comprises two
components: “custom manufacturing” (manufacturing chemicals for specific
customers); and “performance chemicals” (multi-customer specialty
chemicals).
Biofuels
FutureFuel’s
biofuels business segment manufactures and markets
biodiesel. Biodiesel revenues are generally derived in one of two
ways. Revenues are generated under tolling agreements whereby
customers supply key biodiesel feed stocks which FutureFuel then converts into
biodiesel at the Batesville Plant in exchange for a fixed price processing
charge per gallon of biodiesel produced. Revenues are also generated
through the production and sale of biodiesel to customers through FutureFuel’s
distribution network at the Batesville Plant and through distribution facilities
available at a leased oil storage facility near Little Rock, Arkansas at
negotiated prices.
Summary
of long-lived assets and revenues by geographic area
All of
FutureFuel’s long-lived assets are located in the U.S.
Most of
FutureFuel’s sales are transacted with title passing at the time of shipment
from the Batesville Plant, although some sales are transacted based on title
passing at the delivery point. While many of FutureFuel’s chemicals
are utilized to manufacture products that are shipped, further processed and/or
consumed throughout the world, the chemical products, with limited exceptions,
generally leave the United States only after ownership has transferred from
FutureFuel to the customer. Rarely is FutureFuel the exporter of
record, never is FutureFuel the importer of record into foreign countries and
FutureFuel is not always aware of the exact quantities of its products that are
moved into foreign markets by its customers. FutureFuel does track
the addresses of its customers for invoicing purposes and uses this address to
determine whether a particular sale is within or without the United
States. FutureFuel’s revenues for the three months ended
September 30, 2008 and 2007 attributable to the United States and foreign
countries (based upon the billing addresses of its customers) were as
follows:
Three
Months Ended
|
|
United
States
|
|
|
All
Foreign Countries
|
|
|
Total
|
|
September 30,
2008
|
|
$ |
49,618 |
|
|
$ |
10,967 |
|
|
$ |
60,585 |
|
September 30,
2007
|
|
$ |
36,884 |
|
|
$ |
9,674 |
|
|
$ |
46,558 |
|
FutureFuel’s
revenues for the nine months ended September 30, 2008 and 2007 attributable
to the United States and foreign countries (based upon the billing addresses of
its customers) were as follows:
Nine
Months Ended
|
|
United
States
|
|
|
All
Foreign Countries
|
|
|
Total
|
|
September 30,
2008
|
|
$ |
128,283 |
|
|
$ |
25,418 |
|
|
$ |
153,701 |
|
September 30,
2007
|
|
$ |
105,066 |
|
|
$ |
20,619 |
|
|
$ |
125,685 |
|
For the
three months ended September 30, 2008 and 2007, revenues from Mexico
accounted for 9% and 11%, respectively, of total revenues. For the
nine months ended September 30, 2008 and 2007, revenues from Mexico
accounted for 10% and 11%, respectively, of total revenues. Beginning
in the third quarter of 2007,
FutureFuel Chemical Company began selling significant quantities of biodiesel to
companies in Canada, at which time revenues from Canada became a material
component of total revenues. For both the three months ended
September 30, 2008 and 2007, revenues from Canada accounted for 9% of total
revenues. For the nine months ended September 30, 2008 and 2007,
revenues from Canada accounted for 6% and 4%, respectively, of total
revenues. Other than Mexico and Canada, revenues from a single
foreign country during the three and nine months ended September 30, 2008
and 2007 did not exceed 2% of total revenues.
Notes
to Consolidated Financial Statements of FutureFuel Corp.
(Dollars
in thousands, except per share amounts)
(Unaudited)
Summary
of business by segment
|
For
the three months ended
September 30,
|
|
For
the nine months ended
September 30,
|
|
|
2008 |
|
2007 |
|
2008
|
|
2007
|
|
Revenues
|
|
|
|
|
|
|
|
Chemicals
|
|
$ |
41,800 |
|
|
$ |
35,668 |
|
|
$ |
114,496 |
|
|
$ |
105,737 |
|
Biofuels
|
|
|
18,785 |
|
|
|
10,890 |
|
|
|
39,205 |
|
|
|
19,948 |
|
Revenues
|
|
$ |
60,585 |
|
|
$ |
46,558 |
|
|
$ |
153,701 |
|
|
$ |
125,685 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment
gross margins
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chemicals
|
|
$ |
8,306 |
|
|
$ |
8,326 |
|
|
$ |
23,742 |
|
|
$ |
19,047 |
|
Biofuels
|
|
|
2,574 |
|
|
|
(1,441 |
) |
|
|
2,170 |
|
|
|
(9,028 |
) |
Segment
gross margins
|
|
|
10,880 |
|
|
|
6,885 |
|
|
|
25,912 |
|
|
|
10,019 |
|
Corporate
expenses
|
|
|
(2,154 |
) |
|
|
(2,247 |
) |
|
|
(6,102 |
) |
|
|
(5,539 |
) |
Income
before interest and taxes
|
|
|
8,726 |
|
|
|
4,638 |
|
|
|
19,810 |
|
|
|
4,480 |
|
Interest
and other income
|
|
|
671 |
|
|
|
877 |
|
|
|
2,585 |
|
|
|
2,695 |
|
Interest
and other expense
|
|
|
(555 |
) |
|
|
(3 |
) |
|
|
(394 |
) |
|
|
(79 |
) |
Provision
for income taxes
|
|
|
(3,453 |
) |
|
|
(2,169 |
) |
|
|
(7,539 |
) |
|
|
(2,886 |
) |
Net
income
|
|
$ |
5,389 |
|
|
$ |
3,343 |
|
|
$ |
14,462 |
|
|
$ |
4,210 |
|
Depreciation
is allocated to segment costs of goods sold based on plant usage. The
total assets and capital expenditures of FutureFuel have not been allocated to
individual segments as large portions of these assets are shared to varying
degrees by each segment, causing such an allocation to be of little
value.
Gross
margin for the biodiesel segment for the nine months ended September 30,
2008 was favorably impacted by the receipt of $2,000 from the State of Arkansas
during the second quarter resulting from our biodiesel operating cost grant
application under the Arkansas Alternative Fuels Development
Program. This funding was attributable to our biodiesel production
between January 1, 2007 and December 31, 2007 and was calculated as
$0.20 per gallon of biodiesel produced, capped at $2,000. FutureFuel
has applied for funding under this program for biodiesel produced during the
period July 1 to September 30, 2008 but has not yet received
notification that its application has been approved. Based on the
characteristics of the Arkansas Alternative Fuels Development Program and the
State funding behind this program, FutureFuel recognizes income in the period
funding is received.
11) Fair
value measurements
FutureFuel
adopted Statement of Financial Accounting Standards (“SFAS”) No. 157, Fair Value Measurements,
effective January 1, 2008. Under SFAS No. 157, fair value
is defined as the exit price, or the amount that would be received to sell an
asset or paid to transfer a liability in an orderly transaction between market
participants as of the measurement date. SFAS No. 157 also
establishes a hierarchy for inputs used in measuring fair value that maximizes
the use of observable inputs and minimizes the use of unobservable inputs by
requiring that the most observable inputs be used when
available. Observable inputs are inputs market participants would use
in valuing the asset or liability developed based on market data obtained from
sources independent of FutureFuel. Unobservable inputs are inputs
that reflect FutureFuel’s assumptions about the factors market participants
would use in valuing the asset or liability developed based upon the best
information available in the circumstances. The hierarchy is broken
down into
three levels. Level 1 inputs are quoted prices (unadjusted) in
active markets for identical assets or liabilities. Level 2
inputs include quoted prices for similar assets or liabilities in active
markets, quoted prices for identical or similar assets or liabilities in markets
that are not active, and inputs (other than quoted prices) that are observable
for the asset or liability, either directly or
indirectly. Level 3 inputs are unobservable inputs for the asset
or liability. Categorization within the valuation hierarchy is based
upon the lowest level of input that is significant to the fair value
measurement.
Notes
to Consolidated Financial Statements of FutureFuel Corp.
(Dollars
in thousands, except per share amounts)
(Unaudited)
The
following table provides information by level for assets and liabilities that
are measured at fair value, as defined by SFAS No. 157, on a recurring
basis.
|
|
Asset/(Liability)
|
|
|
|
Fair
Value at September 30,
|
|
|
Fair
Value Measurements Using
Inputs
Considered as
|
|
Description
|
|
2008
|
|
|
Level
1
|
|
|
Level
2
|
|
|
Level
3
|
|
Available
for sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S.
treasury securities
|
|
$ |
31,900 |
|
|
$ |
31,900 |
|
|
$ |
- |
|
|
$ |
- |
|
Auction
rate securities
|
|
$ |
25,619 |
|
|
$ |
- |
|
|
$ |
25,619 |
|
|
$ |
- |
|
Derivative
instruments
|
|
$ |
(1,916 |
) |
|
$ |
(1,916 |
) |
|
$ |
- |
|
|
$ |
- |
|
12) Subsequent
events
On
October 1, 2008 FutureFuel declared a special cash dividend of U.S. $0.70
per share on our common stock, with a record date of October 22, 2008 and a
payment date of November 11, 2008.
Item
2. Management’s Discussion and Analysis of Financial Condition and Results of
Operations.
The
following Management’s Discussion and Analysis of Financial Condition and
Results of Operations should be read together with our consolidated financial
statements, including the notes thereto, set forth herein. This
discussion contains forward-looking statements that reflect our current views
with respect to future events and financial performance. Actual
results may differ materially from those anticipated in these forward-looking
statements. See “Forward Looking Information” below for additional
discussion regarding risks associated with forward-looking
statements.
Results
of Operations
In General
FutureFuel
Chemical Company’s historical revenues have been generated through the sale of
specialty chemicals. FutureFuel Chemical Company breaks its chemicals
business into two main product groups: custom manufacturing and performance
chemicals. Major products in the custom manufacturing group include:
(i) nonanoyloxybenzenesulfonate, a bleach activator manufactured
exclusively for The Procter & Gamble Company for use in a household
detergent; (ii) a proprietary herbicide (and intermediates) manufactured
exclusively for Arysta LifeScience North America Corporation, a major life
sciences company; and (iii) two other product lines (CPOs and DIPBs)
produced under conversion contracts for Eastman Chemical Company. The
major product line in the performance chemicals group is SSIPA/LiSIPA, polymer
modifiers that aid the properties of nylon manufactured for a broad customer
base. There are a number of additional small volume custom and
performance chemical products that FutureFuel Chemical Company groups into
“other products”. In late 2005, FutureFuel Chemical Company began
producing biodiesel as a product. Beginning in 2006, revenues and
cost of goods sold for biofuels were treated as a separate business
segment.
Revenues
generated from the bleach activator are based on a supply agreement with the
customer. The supply agreement stipulates selling price per kilogram
based on volume sold, with price moving up as volumes move down, and
vice-versa. The current contract expires in March
2013. FutureFuel Chemical Company pays for raw materials required to
produce the bleach activator. The contract with the customer provides
that the price received by FutureFuel Chemical Company for the bleach activator
is indexed to changes in certain items, enabling FutureFuel Chemical Company to
pass along most inflationary increases in production costs to the
customer.
FutureFuel
Chemical Company has been the exclusive manufacturer for its customer of a
proprietary herbicide and certain intermediates. These products are
beginning to face some generic competition, and no assurances can be given that
FutureFuel Chemical Company will remain the exclusive manufacturer for this
product line. The contracts automatically renew for successive
one-year periods, subject to the right of either party to terminate the contract
not later than 270 days prior to the end of the then current term for the
herbicide and not later than 18 months prior to the then current term for
the intermediates. No assurances can be given that these contracts
will not be terminated. The customer supplies most of the key raw
materials for production of the proprietary herbicide. There is no
pricing mechanism or specific protection against cost changes for raw materials
or conversion costs that FutureFuel Chemical Company is responsible for
purchasing and/or providing.
CPOs are
chemical intermediates that promote adhesion for plastic coatings and DIPBs are
intermediates for production of Eastman Chemical Company products used as
general purpose inhibitors, intermediates or antioxidants. As part of
our acquisition of FutureFuel Chemical Company, FutureFuel Chemical Company
entered into conversion agreements with Eastman Chemical Company that
effectively provide a conversion fee to FutureFuel Chemical Company for DIPB
based on volume manufactured, with a minimum annual fee for both
products. In addition, the conversion agreements provide for revenue
adjustments for actual price of raw materials purchased by FutureFuel Chemical
Company at standard usages. Eastman Chemical Company provides key raw
materials at no cost. For the key raw materials, usage over standard
is owed Eastman Chemical Company; likewise, any improvement over standard is
owed to FutureFuel Chemical Company at the actual price Eastman Chemical Company
incurred for the key raw material.
SSIPA/LiSIPA
revenues are generated from a diverse customer base of nylon fiber
manufacturers. Contract sales are indexed to key raw materials for
inflation; otherwise, there is no pricing mechanism or specific protection
against raw material or conversion cost changes.
Other
products include agricultural intermediates and additives, imaging chemicals,
fiber additives and various specialty pharmaceutical intermediates that
FutureFuel Chemical Company has in full commercial production or in
development. These products are currently sold in small quantities to
a large customer base. Pricing for these products is negotiated
directly with the customer (in the case of custom manufacturing) or is
established based upon competitive market conditions (in the case of performance
chemicals). In general, these products have no pricing mechanism or
specific protection against raw material or conversion cost
changes.
The year
ended December 31, 2006 was the first full year that FutureFuel Chemical
Company sold biodiesel. Capacity was initially 3 million gallons
per year, increasing to 24 million gallons per year by the end of 2007
through a dedicated continuous processing line and, to a lesser extent, batch
processing. During 2006 and 2007, FutureFuel Chemical Company sold
for its own account and produced, for a fee, biodiesel for a third party under a
tolling agreement. The tolling agreement terminated on
September 30, 2007 and was not renewed. Today, FutureFuel
Chemical Company procures all of its own feedstock and only sells biodiesel for
its own account. In rare instances, FutureFuel Chemical Company
purchases biodiesel from other producers for resale. FutureFuel
Chemical Company has the capability to process multiple types of vegetable oils
and animal fats, it can receive feedstock by rail or truck, and it has completed
the construction of substantial storage capacity to acquire feedstock at
advantaged prices when market conditions permit. We have plans to
increase FutureFuel Chemical Company’s production capacity to 59 million
gallons of biodiesel per year by the first quarter of 2009 through the addition
of a second continuous processing line. We believe we have
successfully demonstrated our ability to keep our existing continuous processing
line at or near capacity for sustained periods of time as well as our ability to
both procure and logistically handle large quantities of
feedstock. Uncertainty related to our future biodiesel production
relates to changes in feedstock prices relative to biodiesel prices and also the
$1 per gallon federal blenders credit, which has been extended to the end of
2009. Please see Part II, Item 1.A. below for additional discussion
of this risk.
The
majority of our and FutureFuel Chemical Company’s expenses are cost of goods
sold. Cost of goods sold reflects raw material costs as well as both
fixed and variable conversion costs, conversion costs being those expenses that
are directly or indirectly related to the operation of FutureFuel Chemical
Company’s plant. Significant conversion costs include labor,
benefits, energy, supplies and maintenance and repair. In addition to
raw material and conversion costs, cost of goods sold includes environmental
reserves and costs related to idle capacity. Finally, cost of goods
sold includes hedging gains and losses recognized by us. Cost of
goods sold is allocated to the chemical and biofuels business segments based on
equipment and resource usage for most conversion costs and based on revenues for
most other costs.
Operating
costs include selling, general and administrative and research and development
expenses. These expense categories include expenses that were
directly incurred by us and FutureFuel Chemical Company.
The
discussions of results of operations that follow are based on revenues and
expenses in total and for individual product lines and do not differentiate
related party transactions.
Three Months Ended September 30, 2008 Compared to Three Months Ended
September 30, 2007
Revenues: Revenues for the
quarter ended September 30, 2008 were $60,585,000 as compared to revenues
for the quarter ended September 30, 2007 of $46,558,000, an increase of
30%. The increase was mainly attributable to increased volumes and
prices of biodiesel, the proprietary herbicide and intermediates and SSIPA; all
product lines increased at least 3% over the third quarter of
2007. Revenues from biofuels increased 72% and accounted for 31% of
total revenues in 2008 as compared to 23% in 2007. Revenues from
chemicals increased 17% and accounted for 69% of total revenues in 2008 as
compared to 77% in 2007. Within the chemicals segment, revenues for
the third quarter of 2008 changed as follows as compared to the third quarter of
2007: revenues from the bleach activator increased 12%; revenues from the
proprietary herbicide and intermediates increased 43%; revenues from CPOs
increased 8%; revenues from DIPBs increased 3%; revenues from SSIPA/LiSIPA
increased 41%; and revenues from other products increased 5%.
Sales
volumes of the bleach activator during the quarter ended September 30, 2008
were slightly higher than the quarter ended September 30, 2007 and were
generally in-line with expectations. The 12% increase in revenue was
mainly attributable to higher prices that resulted from contractual inflationary
increases of certain raw material prices. We have experienced
relatively stable demand from this customer since the first quarter of 2007 and
are not aware of
any particular market or customer-specific dynamic that would materially change
this trend in the fourth quarter of 2008 or in 2009.
At
present, revenues from the bleach activator and the proprietary herbicide and
intermediates are together the most significant components of FutureFuel
Chemical Company’s revenue base, together accounting for 51% of revenues in the
quarter ended September 30, 2008 as compared to 56% in the quarter ended
September 30, 2007. The future volume of and revenues from the
bleach activator depend on both consumer demand for the product containing the
bleach activator and the manufacturing, sales and marketing priorities of our
customer. We are unable to predict with certainty the revenues we
will receive from this product in the future. We believe our customer
for the proprietary herbicide has been able to maintain its volume in light of
generic competition by being more price competitive, changing its North American
distribution system and developing new applications. In addition, our
customer has benefited from the general increase in planted acreage in the
markets it serves.
Revenues
from CPOs and DIPBs together increased 6% during the third quarter of 2008, due
mainly to higher prices stemming from contractual inflationary increases of
certain raw material prices and conversion costs. We believe our
customer is actively seeking new customers and new applications for these
products; if successful we may see modest volume improvement for one or both
product lines in 2009. However, both of these products are late in
their life cycle and both are negatively impacted by the automotive and housing
slow down. As a result, future market conditions for both CPOs and
DIPBs may be challenging.
The
majority of the increased revenues from biodiesel stem from higher selling
prices during the third quarter of 2008 as compared to the third quarter of
2007. In addition, gallons of biodiesel sold during the third quarter
of 2008 were 20% greater than the same period of 2007; this volume increase was,
in turn, due to stronger demand from certain key bulk
customers. FutureFuel Chemical Company was able to support this
increased demand by running at or near capacity production rates during most of
the third quarter of 2008. There were no material shutdowns and we
leveraged our newly built storage capacity and expanded infrastructure, as well
as our fleet of leased railcars, to meet customer requirements during the peak
demand season for biodiesel.
Cost of Goods Sold and
Distribution: Total cost of goods sold and distribution for
the quarter ended September 30, 2008 were $49,705,000 as compared to total
cost of goods sold and distribution for the quarter ended September 30,
2007 of $39,673,000, an increase of 25%.
Cost of
goods sold and distribution for the quarter ended September 30, 2008 for
FutureFuel Chemical Company’s chemicals segment were $33,494,000 as compared to
cost of goods sold and distribution for the quarter ended September 30,
2007 of $27,342,000. On a percentage basis, cost of goods sold and
distribution increased more than revenues. This is due to sharply
higher raw material prices experienced during most of the third quarter of
2008. FutureFuel Chemical Company is able to pass the majority of raw
material prices increases on to its customers via contractual inflationary price
adjustments. However, increases in prices of finished products via
these contractual adjustments lag increases in raw material prices by one
quarter. Increased cost of goods sold and distribution for the
chemicals segment were partially offset by increased sales of biodiesel during
the third quarter of 2008, which in turn pulled a greater share of fixed cost
away from the chemicals segment as compared to the third quarter of
2007.
Cost of
goods sold and distribution for the third quarter of 2008 for FutureFuel
Chemical Company’s biofuels segment were $16,211,000 as compared to cost of
goods sold and distribution for the third quarter of 2007 of
$12,331,000. On a percentage basis, cost of goods sold and
distribution increased 31% against increased revenues of 72%, resulting in
increased margins on biodiesel for the third quarter of 2008 as compared to the
third quarter of 2007. These increased margins are a result of
economies of scale that result from higher volumes of biodiesel produced and
sold. In addition, margins were favorably impacted by gains on
hedging activity of $2,290,000 during the third quarter of 2008 as compared to
losses of $1,563,000 during the third quarter of 2007. Excluding
these gains the biofuels segment was still profitable on a fully allocated basis
during the third quarter of 2008. Cost of goods sold and distribution
for the biofuels segment does not include any funding from the State of Arkansas
under the Arkansas Alternative Fuels Development Program, although we did submit
an application for such funding. Under this program, biodiesel
producers in the state of Arkansas are eligible to receive $0.20 per gallon for
every gallon of biodiesel produced during defined time periods, up to a maximum
of $2,000,000 per period. FutureFuel Chemical Company applied for and
received the maximum $2,000,000 funding under this program for biodiesel
produced between January 1, 2007 and June 30, 2008. The
next eligible application period opened July 1, 2008 and closes
June 30, 2009. FutureFuel Chemical Company has applied for the
$0.20 per gallon credit for biodiesel produced during the third quarter of
2008. Due to the uncertainty of funding from this program, we do not
recognize a credit to cost of goods sold and distribution until such time as our
application is approved and funding is received.
Operating
Expenses: Operating expenses decreased from $2,247,000 for the
quarter ended September 30, 2007 to $2,154,000 for the quarter ended
September 30, 2008, or 4%. This decrease was primarily
attributable to lower compensation expense which, in turn, resulted from lower
director fees.
Provision for Income
Taxes: The effective tax rates for the three months ended
September 30, 2008 and 2007 reflect our expected tax rate on reported
operating earnings before income taxes. We have determined that we do
not believe that we have a more likely than not probability of realizing a
portion of our deferred tax assets. As such, we have recorded a
valuation allowance of $935,000 at September 30, 2008.
Nine Months Ended September 30,
2008 Compared to Nine Months Ended September 30, 2007
Revenues: Revenues
for the nine months ended September 30, 2008 were $153,701,000 as compared
to revenues for the nine months ended September 30, 2007 of $125,685,000,
an increase of 22%. The increase was mainly attributable to increased
volumes of biodiesel produced and sold; revenues for the chemical business as a
whole increased 8%, contributing modestly to the overall
increase. Revenues from biofuels increased 97% and accounted for 25%
of total revenues in 2008 as compared to 16% in 2007. Revenues from
chemicals increased 8% and accounted for 75% of total revenues in 2008 as
compared to 84% in 2007. Within the chemicals segment, revenues for
the first nine months of 2008 changed as follows as compared to the first nine
months of 2007: revenues from the bleach activator increased 5%; revenues from
the proprietary herbicide and intermediates increased 26%; revenues from CPOs
increased 15%; revenues from DIPBs decreased 15%; revenues from SSIPA/LiSIPA
increased less than 1%; and revenues from other products increased
12%.
Revenues
from the bleach activator were generally in-line with
expectations. We have experienced relatively stable demand from this
customer since the first quarter of 2007 and are not aware of any particular
market or customer-specific dynamic that would materially change this trend in
the fourth quarter of 2008 or 2009.
At
present, revenues from the bleach activator and the proprietary herbicide and
intermediates are together the most significant components of FutureFuel
Chemical Company’s revenue base, together accounting for 55% of revenues in the
first nine months of 2008 as compared to 61% in first nine months of
2007. The future volume of and revenues from the bleach activator
depend on both consumer demand for the product containing the bleach activator
and the manufacturing, sales and marketing priorities of our
customer. We are unable to predict with certainty the revenues we
will receive from this product in the future. We believe our customer
has been able to maintain its volume in light of generic competition by being
more price competitive, changing its North American distribution system and
developing new applications.
Revenues
from CPOs and DIPBs together decreased 2% during the first nine months of 2008,
due to a 15% reduction in DIPB revenues, which in turn is attributable to
increased competition in our customer’s market and the general decline in the
housing and building industries, which are large
consumers of DIPB end products. Revenues from DIPB steadily
declined from the first quarter of 2007 through the second quarter of 2008 as
these market conditions came into effect. The market stabilized
during the third quarter of 2008 and revenues from DIPB increased modestly
during this period. We believe our customer is actively seeking new
customers and new applications for both products; if successful we may see
modest volume improvement for one or both product lines in
2009. However, both of these products are late in their life cycle
and both are negatively impacted by the automotive and housing slow
down. As a result, future market conditions for both CPOs and DIPBs
may be challenging.
Revenue
from biodiesel increased in the first nine months of 2008 due to higher selling
prices for biodiesel, increased capacity utilization and increased demand from
certain core customers. FutureFuel Chemical Company’s continuous
production line was shut down from February 2007 to May 2007 as a result of a
fire. This incident negatively impacted production in the first nine
months of 2007. Production during the first nine months of 2008 has
run without any material shutdowns and FutureFuel Chemical Company has
demonstrated on a consistent and sustained basis its ability to run at or near
nameplate capacity of 24 million gallons per year.
Cost of Goods Sold and
Distribution: Total cost of goods sold and distribution for
the nine months ended September 30, 2008 were $127,788,000 as compared to
total cost of goods sold and distribution for the nine months ended
September 30, 2007 of $115,666,000, an increase of 10%.
Cost of
goods sold and distribution for the nine months ended September 30, 2008
for FutureFuel Chemical Company’s chemicals segment were $90,753,000 as compared
to cost of goods sold and distribution for the nine months ended
September 30, 2007 of $86,690,000. This reflects an increase of
5% which is generally in line with increased revenues during the nine month
period of 8%. The modest increase in margins is attributable to
increased volumes of biodiesel sold, which pulled fixed cost away from the
chemicals segment. The decrease is also due to the results of
plant-wide cost reduction efforts that had not yet been completed as of the end
of the first nine months of 2007. These factors were partially offset
by significant increases in raw material prices during the first nine months of
2008 (the second and third quarters in particular) as compared to the same
period a year earlier. In some cases FutureFuel Chemical Company has
price protection built into its long-term contracts and in other cases
FutureFuel Chemical Company is able to pass along price increases to its
customers. However, the contractual inflationary price adjustments to
pricing under long-term contracts lag raw material price increases by one
quarter.
Cost of
goods sold and distribution for the nine months ended September 30, 2008
for FutureFuel Chemical Company’s biofuels segment were $37,035,000 as compared
to cost of goods sold and distribution for the nine months ended
September 30, 2007 of $28,976,000. On a percentage basis, cost
of goods sold and distribution for the biofuels segment increased 28% from 2007
to 2008 while revenues increased 97%. FutureFuel Chemical Company was
able to offset volume-based increases in cost through the following
initiatives. First, we received $2 million from the State of
Arkansas resulting from our biodiesel operating cost grant application under the
Arkansas Alternative Fuels Development Program; there was no similar funding
under this program received during the first nine months of 2007. As
previously discussed, we have applied for additional funding under the program
for biodiesel produced during the third quarter of 2008 but will not recognize a
credit to cost of goods sold and distribution until our application is approved
and funding is received. Second, we sold certain biodiesel feedstock
during the second quarter of 2008 based on an analysis of market value relative
to product margins from converting the feedstock; these sales are recorded as an
offset to cost of goods sold and distribution. We intend to continue
pursuing these opportunities where appropriate. Third, we produced
biodiesel primarily in batch processes during the first quarter of 2007 as a
result of the fire in early February that disabled our continuous
line. During 2008, we produced almost entirely in the continuous
line, with the exception of several weeks in June when produced in batch
processes to meet a seasonal peak in demand. The continuous line is
more efficient and produces higher volumes per reactor than the batch process
and absorbs fewer overhead costs per gallon of biodiesel produced. We
will continue to focus our production on our continuous line, utilizing batch
processes only to achieve higher capacity rates when market conditions so
warrant, to test new processing techniques, and to experiment with various
alternative feedstock. Lastly, the biofuels segment recognized a loss
of $1,786,000 during the first nine months of 2008 related to hedging
activities, less than the loss of $5,090,000 recognized during the same period
of 2007. These losses stem from increasing prices of heating oil and
related energy commodities during the respective time periods; we generally sell
futures contracts and/or options on futures contracts at the time we make volume
and price commitments on feedstock purchases. In a rising price
environment this strategy will result in losses on hedging
activity. However, these losses are offset by larger than anticipated
profits on the sale of physical inventory. Additionally, the use of
hedging instruments enables us to commit to large feedstock purchases and to
store both feedstock and biodiesel inventory for long periods of time without
exposure to risk of swings in energy prices.
Operating
Expenses: Operating expenses increased from $5,539,000 for the
nine months ended September 30, 2007 to $6,102,000 for the nine months
ended September 30, 2008, or approximately 10%. This increase
was primarily attributable to two factors. First, compensation
expense increased $293, or 17%, during the first nine months of 2008; stock
option expense, which had not been incurred prior to the second quarter of 2008,
accounted for the majority of this increase. Second, research and
development expense increased $426, or 16%. This increase is a result
of an influx of new opportunities in 2008 (both custom manufacturing and
multi-customer proprietary projects) that require research and development hours
to review.
Provision for Income
Taxes: The effective tax rates for the nine months ended
September 30, 2008 and 2007 reflect our expected tax rate on reported
operating earnings before income taxes. The reduced rate in the first
nine months of 2008 as compared to the first nine months of 2007 is a result of
our investments in certain tax-free securities during 2008. We have
determined that we do not believe that we have a more likely than not
probability of realizing a
portion of our deferred tax assets. As such, we have recorded a
valuation allowance of $935,000 at September 30,
2008.
Critical
Accounting Estimates
Revenue
Recognition: For most product sales, revenue is recognized
when product is shipped from our facilities and risk of loss and title have
passed to the customer, which is in accordance with our customer contracts and
the stated shipping terms. All custom manufactured products are
manufactured under written contracts. Performance chemicals and
biodiesel are sold pursuant to the terms of written purchase
orders. In general, customers do not have any rights of return,
except for quality disputes. However, all of our products are tested
for quality before shipment, and historically returns have been
inconsequential. We do not offer volume discounts, rebates or
warranties.
Revenue
from bill and hold transactions in which a performance obligation exists is
recognized when the total performance obligation has been met. Bill
and hold transactions for three specialty chemical customers in 2008 and two
specialty chemical customers in 2007 related to revenue that was recognized in
accordance with contractual agreements based on product produced and ready for
use. These sales were subject to written monthly purchase orders with
agreement that production was reasonable. The inventory was custom
manufactured and stored at the customer’s request and could not be sold to
another buyer. Credit and payment terms for bill and hold customers
are similar to other specialty chemical customers. Sales revenue
under bill and hold arrangements were $34,088,000 and $22,671,000 for the nine
months ended September 30, 2008 and 2007, respectively. Bill and
hold revenue was higher in 2008 primarily from converting one customer’s product
line entirely to a bill and hold arrangement.
Liquidity
and Capital Resources
Our
consolidated net cash provided by (used in) operating activities, investing
activities and financing activities for the nine months ended September 30,
2008 and 2007 are set forth in the following chart.
(Dollars
in thousands)
|
|
September 30,
2008
|
|
|
September 30,
2007
|
|
Net
cash provided by operating activities
|
|
$ |
27,029 |
|
|
$ |
19,103 |
|
Net
cash used in investing activities
|
|
$ |
(55,214 |
) |
|
$ |
(28,119 |
) |
Net
cash provided by (used in) financing activities
|
|
$ |
957 |
|
|
$ |
(50 |
) |
Operating
Activities: Cash provided by operating activities increased
from $19,103 during the first nine months of 2007 to $27,029 during the first
nine months of 2008. The increase in cash provided by operating
activities is a result of a $10,252 increase in net income, a $7,461 increase in
cash provided by the change in deferred revenue and a $2,060 increase in cash
provided by the change in other assets. Partially offsetting these
increases are a $9,419 decrease in cash used in the change in accounts
receivable, a $4,322 decrease in cash used in the change in accounts payable and
a $1,126 decrease in cash used in the change in income taxes
payable.
Other
than the changes in cash discussed above, no single item resulted in a greater
or less than $1 million change in cash provided from operating activities
between the two nine-month periods of 2007 and 2008.
Investing
Activities: Cash used in investing activities increased from
$28,119 in the nine months ended September 30, 2007 to $55,214 in the nine
months ended September 30, 2008. $25,600 of this $27,095
increase resulted from the purchase of auction rate securities during the nine
months ended September 30, 2008. These investments are further
described below under “Capital Management”.
Financing
Activities: Cash used in financing activities was $50 in the
first nine months of 2007 as compared to cash provided by financing activities
of $957 in the first nine months of 2008. Financing activities during
2007 consisted solely of the payment of a bank financing
fee. Financing activities during 2008 consisted primarily of proceeds
from our line of credit and proceeds from the issuance of stock. The
line of credit is used to manage fluctuations in working capital. The
issuance of stock consisted of the exercise of warrants and
options.
Credit
Facility
FutureFuel
Chemical Company entered into a $50 million credit agreement with a
commercial bank in March 2007. The loan is a revolving facility the
proceeds of which may be used for working capital, capital expenditures and
general corporate purposes of FutureFuel Chemical Company. The
facility terminates in March 2010. Advances are made pursuant to a
borrowing base. Advances are secured by a perfected first priority
security interest in accounts receivable and inventory. The interest
rate floats at certain margins over LIBOR or base rate based upon certain
leverage ratio from time to time.
There is
an unused commitment fee. Beginning December 31, 2007, and on
the last day of each fiscal quarter thereafter, the ratio of EBITDA to fixed
charges may not be less than 1.5:1. Beginning June 30, 2007, the
ratio of total funded debt to EBITDA may not exceed 3.50:1, reduced to 3.25:1 at
March 31, 2008, June 30, 2008 and September 30, 2008, and then
3:1 thereafter. We have guaranteed FutureFuel Chemical Company’s
obligations under this credit agreement.
FutureFuel
Chemical Company had $343,000 of borrowings under this $50 million credit
agreement as of September 30, 2008 and no borrowings as of
December 31, 2007.
We intend
to fund future capital requirements for FutureFuel Chemical Company’s chemical
and biofuels segments from cash flow generated by FutureFuel Chemical Company as
well as from existing cash and borrowings under the credit
facility. We do not believe there will be a need to issue any
securities to fund such capital requirements.
Special
Dividend
On
October 1, 2008, we declared a special cash dividend of U.S. $0.70 per
share on our common stock, with a record date of October 22, 2008 and a
payment date of November 11, 2008.
Off-Balance
Sheet Arrangements
Our only
off-balance sheet arrangements were: (i) the financial assurance trusts
established for the benefit of the Arkansas Department of Environmental Quality;
and (ii) hedging transactions. The financial assurance trusts
were established to provide assurances to the Arkansas Department of
Environmental Quality that, in the event the Batesville facility is closed
permanently, any reclamation activities necessitated under applicable
environmental laws would be completed. The amounts held in trust were
included in restricted cash and cash equivalents on our balance
sheet. The closure liabilities are included in other noncurrent
liabilities, but only on a present value basis. These financial
assurance trusts were terminated on August 8, 2008 and were replaced by our
guaranty. This guaranty is not expected to have a material adverse
effect upon our financial condition.
We engage
in two types of hedging transactions. First, we hedge our biodiesel
sales through the purchase and sale of futures contracts and options on futures
contracts of energy commodities. This activity was captured on our
balance sheet at September 30, 2008 and December 31,
2007. Second, we hedge our biodiesel feedstock through the execution
of purchase contracts and supply agreements with certain
vendors. These hedging transactions are recognized in earnings and
were not recorded on our balance sheet at September 30, 2008 or
December 31, 2007 as they do not meet the definition of a derivative
instrument as defined under accounting principles generally accepted in the
U.S. The purchase of biodiesel feedstock generally involves two
components: basis and price. Basis covers any refining or processing
required as well as transportation. Price covers the purchases of the
actual agricultural commodity. Both basis and price fluctuate over
time. A supply agreement with a vendor constitutes a hedge when
FutureFuel Chemical Company has committed to a certain volume of feedstock in a
future period and has fixed the basis for that volume.
Capital
Management
Over
approximately the last eighteen months, the global financial markets have
experienced significant volatility and fluctuations in credit market
liquidity. In some instances, these market conditions have caused
companies to reconsider the classification of certain investments on their
balance sheets and, in some cases, to record losses on the reduced fair market
value of those investments. To date, as more fully described in the
following paragraphs, we have been able to avoid these problems through our
active management of our short-term investments and cash.
As a
result of our initial equity offering and the subsequent positive operating
results of FutureFuel Chemical Company, we have accumulated excess working
capital. Subsequent to the payment of the previously announced
special dividend of $0.70 per common share, we intend to retain all remaining
cash to fund infrastructure and capacity expansion at FutureFuel Chemical
Company and to pursue complimentary acquisitions in the oil and gas and chemical
industries. While in the present state of having excess working
capital, we intend to manage these assets in such a way as to generate
sufficient returns on these funds. Third parties have not placed
significant restrictions on our working capital management
decisions.
In the
first nine months of 2008, the management of these funds has largely taken the
form of investments in U.S. treasury bills and bonds, investments in foreign
denominated government bonds, investments in auction rate securities,
investments in foreign currency and the holding of cash in money market or
similar bank accounts.
Beginning
in late 2007, we made investments in certain U.S. treasury bills and
notes. As of September 30, 2008, our investments in U.S.
treasury debt securities carried maturity dates ranging from November 2008 to
March 2009. We have designated these securities as being
available-for-sale. Accordingly, these securities are carried at fair
value, with the unrealized gains and losses, net of taxes, reported as a
separate component of stockholders’ equity. The fair market value of
these securities, including accrued interest, totaled $31,900,000 at
September 30, 2008.
In 2008
we made an investment in treasury bonds of a certain foreign
government. As of September 30, 2008, the instruments comprising
this investment had matured or been sold and no subsequent, similar investments
had been made.
We have
selectively made investments in certain auction rate securities that we believe
offer sufficient yield along with sufficient liquidity. To date, all
the auction rate securities in which we have invested have maintained a
mechanism for liquidity, meaning that the respective auctions have not failed,
the issuers have called the instruments, or a secondary market exists for
liquidation of the securities. We have classified these instruments
as current assets in the accompanying consolidated balance sheet and carry them
at their estimated fair market value. The fair market value of these
instruments approximated their par value and, including accrued interest,
totaled $25,619,000 at September 30, 2008. Auction rate
securities are typically long term bonds issued by an entity for which there is
a series of auctions over the life of the bond that serve to reset the interest
rate on the bonds to a market rate. These auctions also serve as a
mechanism to provide liquidity to the bond holders; as long as there are
sufficient purchasers of the auction rate securities, the then owners of the
auction rate securities are able to liquidate their investment through a sale to
the new purchasers. In the event of an auction failure, a situation
when there are more sellers than buyers of a particular issue, the current
owners of an auction rate security issue may not be able to liquidate their
investment. As a result of an auction failure, a holder may be forced
to hold the particular security either until maturity or until a willing buyer
is found. Even if a willing buyer is found, however, there is no
guarantee that this willing buyer will purchase the security for its carrying
value, which would result in a loss being realized on the sale. The
liquidity problems currently experienced in the U.S. auction rate securities
markets have generally been focused on closed-end fund and student loan auction
rate securities, asset classes that we have avoided.
In 2008,
we made investments in certain foreign currencies. We exited from
these investments prior to September 30, 2008.
Lastly,
we maintain depository accounts such as checking accounts, money market accounts
and other similar accounts at selected financial institutions.
Other
Matters
We
entered into an agreement with a customer to construct at a fixed price a
processing plant and produce a certain chemical for the customer. We
engaged a third party to act as general contractor on the construction of this
plant for a guaranteed price. That general contractor defaulted on
its obligations under its contract with us and abandoned the
project. As a result, we have undertaken the general contractor role
ourselves. We also filed suit against our former contractor to recoup
any damages that we may incur as a result of his default. The former
contractor has counterclaimed against us for amounts he asserts are due him
under our contract with him. At this time, we are unable to determine
what effect the general contractor’s default and/or his counterclaim will have
on us or on our financial condition.
A
customer entered into a contract with us for the purchase of approximately one
million gallons of biodiesel. The customer defaulted on a portion of
the contract approximately one month later by which time the market price of
biodiesel had declined substantially. Pursuant to the general terms
and conditions of the contract which we had previously agreed to with the
customer, we filed with the American Arbitration Association to recoup our
damages that resulted from the customer’s default. The customer
claims that we breached the contract and has brought suit in court for a
declaratory judgment that we repudiated the contract; that the customer does not
owe us any damages; and for recovery of its court costs and attorneys
fees. At this time we are unable to determine the probability that we
will be successful in recovering our damages. We do not expect that
the customer’s claim against us will have a material impact on our financial
condition.
Item
3. Quantitative and Qualitative Disclosures About Market Risk.
In recent
years, general economic inflation has not had a material adverse impact on
FutureFuel Chemical Company’s costs and, as described elsewhere herein, we have
passed some price increases along to our customers. However, we are
subject to certain market risks as described below.
Market
risk represents the potential loss arising from adverse changes in market rates
and prices. Commodity price risk is inherent in the chemical and
biofuels business both with respect to input (electricity, coal, biofuel
feedstock, etc.) and output (manufactured chemicals and biofuels).
We seek
to mitigate our market risks associated with the manufacturing and sale of
chemicals by entering into term sale contracts that include contractual market
price adjustment protections to allow changes in market prices of key raw
materials to be passed on to the customer. Such price protections are
not always obtained, however, so raw material price risk remains a significant
risk.
In order
to manage price risk caused by market fluctuations in biofuel prices, we may
enter into exchange traded commodity futures and options
contracts. We account for these derivative instruments in accordance
with Statement of Financial Accounting Standards (“SFAS”) No. 133 Accounting for Derivative
Instruments and Hedging Activities, as amended. Under these
standards, the accounting for changes in the fair value of a derivative
instrument depends upon whether it has been designated as an accounting hedging
relationship and, further, on the type of hedging relationship. To
qualify for designation as an accounting hedging relationship, specific criteria
must be met and appropriate documentation maintained. We had no
derivative instruments that qualified under these rules as designated accounting
hedges in 2008 or 2007. Changes in the fair value of our derivative
instruments are recognized at the end of each accounting period and recorded in
the statement of operations as a component of cost of goods sold.
Our
immediate recognition of derivative instrument gains and losses can cause net
income to be volatile from quarter to quarter due to the timing of the change in
value of the derivative instruments relative to the sale of biofuel being
sold. As of September 30, 2008 and December 31, 2007, the
fair values of our derivative instruments were a net liability in the amount of
$1,916,000 and $247,000, respectively.
Our gross
profit will be impacted by the prices we pay for raw materials and conversion
costs (costs incurred in the production of chemicals and biofuels) for which we
do not possess contractual market price adjustment protection. These
items are principally comprised of animal fat, electricity, caustic soda, coal
and natural gas. The availability and price of all of these items are
subject to wide fluctuations due to unpredictable factors such as weather
conditions, overall economic conditions, farmers’ planting decisions,
governmental policies and global supply and demand.
We
prepared a sensitivity analysis of our exposure to market risk with respect to
key raw materials and conversion costs for which we do not possess contractual
market price adjustment protections, based on average prices in the first nine
months of 2008. We included only those raw materials and conversion
costs for which a hypothetical adverse change in price would result in a 1% or
greater decrease in gross profit. Assuming that the prices of the
associated finished goods could not be increased and assuming no change in
quantities sold, a hypothetical 10% change in the average price of the
commodities listed below would result in the following change in annual gross
profit:
Item
|
|
Volume(a)
Requirements
|
|
Units
|
|
Hypothetical
Adverse
Change
in
Price
|
|
|
Decrease
in Gross Profit
|
|
|
Percentage
Decrease in Gross Profit
|
|
Animal
fat
|
|
|
77,358,801 |
|
LB
|
|
|
10.0% |
|
|
$ |
3,447,000
|
|
|
|
13.3% |
|
Electricity
|
|
|
68,388 |
|
MWH
|
|
|
10.0% |
|
|
$ |
369,000
|
|
|
|
1.4%
|
|
__________
(a)
|
Volume
requirements and average price information are based upon volumes used and
prices obtained for the nine months ended September 30,
2008. Volume requirements may differ materially from these
quantities in future years as the business of FutureFuel Chemical Company
evolves.
|
As of
September 30, 2008 and December 31, 2007, we had either insignificant
or no borrowings and, as such, we were not exposed to a significant amount of
interest rate risk.
Item
4. Controls and Procedures.
Under the
supervision and with the participation of our Chief Executive Officer and our
Principal Financial Officer and other senior management personnel, we evaluated
the effectiveness of the design and operation of our disclosure controls and
procedures (as defined in Rules 13a-15(e) and 15(d)-15(e) under the Securities
Exchange Act of 1934, as amended (“Exchange
Act”)) as of the end of the period covered by this
report. Based on that evaluation, our Chief Executive Officer and our
Principal Financial Officer have concluded that these disclosure controls and
procedures as of September 30, 2008 were effective to ensure that
information required to be disclosed in the reports that we file or submit under
the Exchange Act is recorded, processed, summarized and reported within the time
periods specified in the Securities and Exchange Commission’s rules and
forms.
There
were no changes in our internal control over financial reporting during our last
fiscal quarter that materially affected, or were reasonably likely to materially
affect, our internal control over financial reporting.
PART
II
OTHER
INFORMATION
Item
1. Legal Proceedings.
Neither
we nor our subsidiary are a party to, nor is any of ours or their property
subject to, any material pending legal proceedings, other than ordinary routine
litigation incidental to their businesses.
From time
to time, FutureFuel Chemical Company and its operations may be parties to, or
targets of, lawsuits, claims, investigations and proceedings, including product
liability, personal injury, asbestos, patent and intellectual property,
commercial, contract, environmental, antitrust, health and safety and employment
matters, which we expect to be handled and defended in the ordinary course of
business. While we are unable to predict the outcome of any such
matters currently pending, we do not believe that the ultimate resolution of any
such pending matters will have a material adverse effect on our overall
financial condition, results of operations or cash flows. However,
adverse developments could negatively impact earnings or cash flows in future
periods.
Item
1A. Risk Factors.
See our
Amendment No. 3 to Form 10 Registration Statement filed with the Securities
and Exchange Commission on April 9, 2008 for a description of “Risk
Factors” relating to an investment in us. There are no material
changes from the risk factors disclosed in such filing except as
follows.
The
federal excise tax credit for biodiesel expires on December 31, 2009 and
Congress has not enacted legislation to extend this credit. If the
credit expires, FutureFuel Chemical Company’s cost of producing biodiesel will
be increased, which could have an adverse effect on our financial
position.
In
October 2004, Congress passed a biodiesel tax incentive, structured as a federal
excise tax credit, as part of the American Jobs Creation Act of
2004. The credit amounts to one cent for each percentage point of
vegetable oil or animal fat biodiesel that is blended with petrodiesel (and
one-half cent for each percentage point of recycled oils and other
non-agricultural biodiesel). For example, blenders that blend B20
made from soy, canola and other vegetable oils and animal fats receive a 20¢ per
gallon excise tax credit, while biodiesel made from recycled restaurant oils
(yellow grease) receive half of this credit. The tax incentive
generally is taken by petroleum distributors and is passed on to the
consumer. It is designed to lower the cost of biodiesel to consumers
in both taxable and tax-exempt markets. The tax credit was scheduled
to expire at the end of 2006, but was extended in the Energy Policy Act of 2005
to December 31, 2008 and most recently it was extended to December 31,
2009.
Congress
has not enacted any legislation to extend this tax credit beyond
December 31, 2009. If the tax credit is not extended, FutureFuel
Chemical Company’s biodiesel production costs will increase by $1.00 per
gallon. If biodiesel feedstock costs do not decrease significantly
relative to biodiesel prices by the beginning of 2010, FutureFuel Chemical
Company would realize a negative biodiesel production margin. As a
result, we would cease producing biodiesel, which could have an adverse effect
on our financial condition.
The
U.S. biodiesel manufacturing base is contracting. This contraction
may adversely affect FutureFuel Chemical Company’s ability to sell
biodiesel.
At least
275 million gallons of biodiesel production/new construction has been
halted or suspended since January 1, 2008. Further industry
consolidation is expected. This industry contraction could affect the
willingness of potential customers to purchase biodiesel if they perceive that
the biodiesel market is not a stable long-term supply of product, which could
adversely affect our sales and results of operations.
Anti-subsidy
and anti-dumping complaints have been filed with the European Commission
concerning imports of biodiesel originating in the United States. The
existence of such complaints, and an adverse decision by the European
Commission, could reduce demand for biodiesel produced in the United
States.
Anti-subsidy
and anti-dumping complaints have been filed with the European Commission
concerning imports of biodiesel originating in the United
States. Although we are not a target of such complaints and do not
import biodiesel into the European community, the existence of such complaints,
and an adverse decision by the European Commission,
could reduce demand for biodiesel produced in the United States. Such
a reduction in demand could reduce the amount of biodiesel that FutureFuel
Chemical Company sells, which could have an adverse effect on our financial
condition.
Item
2. Unregistered Sales of Equity Securities and Use of Proceeds.
None.
Item
3. Defaults Upon Senior Securities.
None.
Item
4. Submission of Matters to Vote of Security Holders
None
Item
5. Other Information.
None.
Item
6. Exhibits and Reports on Form 8-K
Exhibit
No.
|
Description
|
31(a)
|
Rule
13a-15(e)/15d-15(e) Certification of chief executive
officer
|
31(b)
|
Rule
13a-15(e)/15d-15(e) Certification of principal financial
officer
|
32
|
Section
1350 Certification of chief executive officer and principal financial
officer
|
Forward
Looking Information
This Form
contains or incorporates by reference “forward-looking
statements”. When used in this document, the words “anticipate,”
“believe,” “estimate,” “expect,” “plan,” and “intend” and similar expressions,
as they relate to us, FutureFuel Chemical Company or our respective management,
are intended to identify forward-looking statements. These
forward-looking statements are based on current management assumptions and are
subject to uncertainties and inherent risks that could cause actual results to
differ materially from those contained in any forward-looking
statement. We caution you therefore that you should not rely on any
of these forward-looking statements as statements of historical fact or as
guarantees or assurances of future performance. Important factors
that could cause actual results to differ materially from those in the
forward-looking statements include regional, national or global political,
economic, business, competitive, market and regulatory conditions as well as,
but not limited to, the following:
·
|
conflicts
of interest of our officers and
directors;
|
·
|
potential
future affiliations of our officers and directors with competing
businesses;
|
·
|
the
control by our founding shareholders of a substantial interest in
us;
|
·
|
the
highly competitive nature of the chemical and alternative fuel
industries;
|
·
|
fluctuations
in energy prices may cause a reduction in the demand or profitability of
the products or services we may ultimately produce or offer or which form
a portion of our business;
|
·
|
changes
in technology may render our products or services
obsolete;
|
·
|
failure
to comply with governmental regulations could result in the imposition of
penalties, fines or restrictions on operations and remedial
liabilities;
|
·
|
the
operations of FutureFuel Chemical Company’s biofuels business may be
harmed if the applicable government were to change current laws and/or
regulations;
|
·
|
our
board may have incorrectly evaluated FutureFuel Chemical Company’s
potential liabilities;
|
·
|
our
board may have FutureFuel Chemical Company engage in hedging transactions
in an attempt to mitigate exposure to price fluctuations in petroleum
product transactions and other portfolio positions which may not
ultimately be successful; and
|
·
|
we
may not continue to have access to capital markets and commercial bank
financing on favorable terms and FutureFuel Chemical Company may lose its
ability to buy on open credit
terms.
|
Although
we believe that the expectations reflected by such forward-looking statements
are reasonable based on information currently available to us, no assurances can
be given that such expectations will prove to have been correct. All
forward-looking statements included in this Form and all subsequent oral
forward-looking statements attributable to us or persons acting on our behalf
are expressly qualified in their entirety by these cautionary
statements. We undertake no obligation to publicly update or revise
any forward-looking statement, whether as a result of new information, future
events or otherwise. Readers are cautioned not to place undue
reliance on any forward-looking statements, which speak only as to their
particular dates.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
FUTUREFUEL
CORP.
By: /s/ Douglas D.
Hommert
Douglas
D. Hommert, Executive Vice President, Secretary
and
Treasurer
Date: November 13,
2008
28